The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
about
Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and ProteinsExtracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.Novel immunocytokine IL12-SS1 (Fv) inhibits mesothelioma tumor growth in nude mice.Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancerImmunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions.Immunocytokines for cancer treatment: past, present and future.Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse.Immunocytokines: a review of molecules in clinical development for cancer therapy.Latent cytokines for targeted therapy of inflammatory disorders.Therapeutic vaccination targeting the tumour vasculature.Quantitative proteomics characterization on the antitumor effects of isodeoxyelephantopin against nasopharyngeal carcinoma.The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activity.Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy.Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation.Current progress in innovative engineered antibodies.Targeted Reconstitution of Cytokine Activity upon Antigen Binding using Split Cytokine Antibody Fusion Proteins.Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer.Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developments.Enhanced Therapeutic Activity of Non-Internalizing Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination With Targeted Interleukin-2.In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) FragmentsA novel dual-cytokine-antibody fusion protein for the treatment of CD38-positive malignanciesEmerging classes of armed antibody therapeutics against cancerSpacer length shapes drug release and therapeutic efficacy of traceless disulfide-linked ADCs targeting the tumor neovasculature
P2860
Q28072319-2E37D570-85B6-4A5D-B72D-78DA8CE66521Q34469107-BB72B5B2-E989-4525-B624-438C3B46B7E2Q35049589-C0452FD0-656F-4B35-A4D6-24BC812D8FA3Q35068030-A150308D-2878-48A3-A8E7-CBCAD595C328Q37485709-1FC3B784-F6DD-4F16-893C-2F6316D16130Q37560208-6AFF1D6D-CBD9-4BB1-8465-CC0F3E663D0EQ37690616-B28A0598-C582-48B8-BA0C-3E5B887F02B6Q38132742-BC0853FC-E8B5-422A-A1A8-CA8397500278Q38167818-8C77518B-1FFF-4133-9B1F-82CA7834F1A0Q38268464-76FF70E7-F528-478D-989F-56340C3B2287Q38486629-68E2E485-434A-4FCA-BC77-35B518032B22Q38905573-430A8200-676E-4FBB-A540-0C57FF2506C7Q38988662-35CA7840-FF13-44A1-A08B-CE16E9030387Q39205186-7FE8C436-BEA1-4F9F-AB0A-137035690526Q40077818-B3D22FB2-D9C6-4B62-B035-0494D6F19EA8Q40949460-A0157EE0-8B8B-476C-BA88-F4BB437F22DAQ47277628-1D4FA733-CC23-44DE-B50B-AC14D651F686Q50864449-1146016D-A354-4C2F-A562-C6BF319D26E3Q51786117-BF224DD2-A973-433E-B8F5-B4349C3088C1Q52565554-1B059159-4A14-4B1E-ACC8-614E59C58DA5Q56568322-F749FA79-3512-45A8-9CC7-6DC043FDF255Q57201583-9972B45A-CC3C-4C9A-9552-65DFA9012F16Q57911948-46E40FB5-34CF-4067-BE41-410FDCAC01D5Q57911963-1568E03A-04F4-4F0C-87E4-FE3FFC1E4F4D
P2860
The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The antibody-based delivery of ...... n combination with paclitaxel.
@en
The antibody-based delivery of ...... n combination with paclitaxel.
@nl
type
label
The antibody-based delivery of ...... n combination with paclitaxel.
@en
The antibody-based delivery of ...... n combination with paclitaxel.
@nl
prefLabel
The antibody-based delivery of ...... n combination with paclitaxel.
@en
The antibody-based delivery of ...... n combination with paclitaxel.
@nl
P2093
P1476
The antibody-based delivery of ...... n combination with paclitaxel.
@en
P2093
Elisa Carugati
Francesca Pretto
Nadine Pasche
Sarah Wulhfard
P304
P356
10.1158/1078-0432.CCR-12-0282
P407
P50
P577
2012-06-12T00:00:00Z